Carole Paley

2.9k total citations
72 papers, 2.0k citations indexed

About

Carole Paley is a scholar working on Genetics, Hematology and Rheumatology. According to data from OpenAlex, Carole Paley has authored 72 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Genetics, 57 papers in Hematology and 16 papers in Rheumatology. Recurrent topics in Carole Paley's work include Hemoglobinopathies and Related Disorders (45 papers), Acute Myeloid Leukemia Research (25 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (20 papers). Carole Paley is often cited by papers focused on Hemoglobinopathies and Related Disorders (45 papers), Acute Myeloid Leukemia Research (25 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (20 papers). Carole Paley collaborates with scholars based in United States, Canada and Italy. Carole Paley's co-authors include Visalam Chandrasekaran, Banu Aygün, Medha Sasané, Jason Esposito, Mei Sheng Duh, Francis Vekeman, Michael S. Ondovik, Morey A. Blinder, Maria R. Baer and Patricia J. Giardina and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Carole Paley

67 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carole Paley United States 22 1.4k 1.2k 558 291 261 72 2.0k
Andrew Will United Kingdom 21 797 0.6× 328 0.3× 331 0.6× 338 1.2× 216 0.8× 53 1.6k
Deborah Hurst United States 17 1.0k 0.7× 788 0.7× 373 0.7× 79 0.3× 330 1.3× 32 1.8k
Cesar Homero Gutiérrez‐Aguirre Mexico 20 805 0.6× 267 0.2× 142 0.3× 84 0.3× 143 0.5× 118 1.2k
Lee Hilliard United States 18 479 0.3× 582 0.5× 168 0.3× 71 0.2× 162 0.6× 54 910
Anders Glomstein Denmark 20 644 0.4× 133 0.1× 245 0.4× 78 0.3× 472 1.8× 42 1.4k
Olga Graciela Cantú‐Rodríguez Mexico 21 825 0.6× 279 0.2× 96 0.2× 71 0.2× 131 0.5× 98 1.2k
Paola De Lorenzo Italy 20 821 0.6× 119 0.1× 378 0.7× 86 0.3× 531 2.0× 50 1.5k
Payal Desai United States 14 497 0.3× 601 0.5× 106 0.2× 97 0.3× 156 0.6× 74 909
Maurizio Miano Italy 19 620 0.4× 146 0.1× 158 0.3× 110 0.4× 174 0.7× 68 1.1k
Nicole A. Mortier United States 18 1.1k 0.7× 1.2k 1.0× 204 0.4× 87 0.3× 316 1.2× 38 1.4k

Countries citing papers authored by Carole Paley

Since Specialization
Citations

This map shows the geographic impact of Carole Paley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carole Paley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carole Paley more than expected).

Fields of papers citing papers by Carole Paley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carole Paley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carole Paley. The network helps show where Carole Paley may publish in the future.

Co-authorship network of co-authors of Carole Paley

This figure shows the co-authorship network connecting the top 25 collaborators of Carole Paley. A scholar is included among the top collaborators of Carole Paley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carole Paley. Carole Paley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boisen, Michael L., Jason W. Brown, Holt Murray, et al.. (2026). Evaluating the Impact of a Standardized Protocol for Managing Refractory Vasoplegia After Cardiopulmonary Bypass. Journal of Cardiothoracic and Vascular Anesthesia.
2.
3.
4.
Vichinsky, Elliott, Alan R. Cohen, Alexis A. Thompson, et al.. (2018). Epidemiologic and clinical characteristics of nontransfusion‐dependent thalassemia in the United States. Pediatric Blood & Cancer. 65(7). e27067–e27067. 19 indexed citations
5.
Lyons, Roger M., Carole Paley, Jason Esposito, et al.. (2017). Relation between chelation and clinical outcomes in lower-risk patients with myelodysplastic syndromes: Registry analysis at 5 years. Leukemia Research. 56. 88–95. 39 indexed citations
6.
Vekeman, Francis, Wendy Y. Cheng, Medha Sasané, et al.. (2015). Medical complications, resource utilization and costs in patients with myelofibrosis by frequency of blood transfusion and iron chelation therapy. Leukemia & lymphoma. 56(10). 2803–2811. 5 indexed citations
7.
Blinder, Morey A., et al.. (2015). Age-Related Emergency Department Reliance in Patients with Sickle Cell Disease. Journal of Emergency Medicine. 49(4). 513–522.e1. 59 indexed citations
8.
Blinder, Morey A., et al.. (2014). High Cost Patients And Cost Patterns From Pediatric To Adult Care In A Medicaid Population With Sickle Cell Disease. Value in Health. 17(3). A137–A137. 1 indexed citations
9.
Heeney, Matthew M., Patricia Adams‐Graves, Elizabeth Yang, et al.. (2014). Comparison of Clinical Outcomes Between Adult and Pediatric Patients (pts) with Sickle Cell Disease (SCD): 3-Year (y) Follow-up in a Prospective, Longitudinal, Noninterventional Registry Trial. Blood. 124(21). 4890–4890. 2 indexed citations
10.
Blinder, Morey A., et al.. (2013). Age‐related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs. Pediatric Blood & Cancer. 60(5). 828–835. 99 indexed citations
11.
Goldberg, Stuart L., Er Chen, Medha Sasané, et al.. (2012). Economic impact on US Medicare of a new diagnosis of myelodysplastic syndromes and the incremental costs associated with blood transfusion need. Transfusion. 52(10). 2131–2138. 34 indexed citations
12.
Wood, John C., Leila Noetzli, Ashok Panigrahy, et al.. (2012). Changes in Pituitary Iron, Volume, and Function Over Two Years in Pediatric Patients Treated with Deferasirox. Blood. 120(21). 3206–3206.
13.
Greenberg, Peter L., Charles Koller, Z. Ioav Cabantchik, et al.. (2010). Prospective assessment of effects on iron-overload parameters of deferasirox therapy in patients with myelodysplastic syndromes. Leukemia Research. 34(12). 1560–1565. 40 indexed citations
14.
Álvarez, Ofelia, et al.. (2009). Adherence to Deferasirox in Children and Adolescents With Sickle Cell Disease During 1-year of Therapy. Journal of Pediatric Hematology/Oncology. 31(10). 739–744. 29 indexed citations
15.
Vlachos, Adrianna, Sarah E. Ball, Niklas Dahl, et al.. (2008). Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. British Journal of Haematology. 142(6). 859–876. 297 indexed citations
16.
Greenberg, Peter L., et al.. (2006). Liver Iron Concentration Measurements Using MRI R2 in MDS Patients in a Deferasirox (Exjade®, ICL670) Phase II Study.. Blood. 108(11). 4846–4846. 2 indexed citations
17.
Adamkiewicz, Thomas V., Miguel R. Abboud, Julio C. Barredo, et al.. (2006). Serum Ferritin in Children with Sickle Cell Disease on Chronic Transfusion: Measure of Iron Overload or End Organ Injury? STOP/STOP II Liver Iron Ancillary Study.. Blood. 108(11). 791–791. 6 indexed citations
18.
Aygün, Banu, et al.. (2002). Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion. 42(1). 37–43. 272 indexed citations
19.
Leonidas, John C., et al.. (1995). Papillary-cystic neoplasm of the pancreas. Pediatric Radiology. 25(7). 509–511. 16 indexed citations
20.
Valderrama, Elsa, et al.. (1994). Systemic necrotizing vasculitis associated with childhood sarcoidosis. Seminars in Arthritis and Rheumatism. 23(6). 388–395. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew Will Breakdown of academic impact, for papers by Deborah Hurst Breakdown of academic impact, for papers by Cesar Homero Gutiérrez‐Aguirre Breakdown of academic impact, for papers by Lee Hilliard Breakdown of academic impact, for papers by Anders Glomstein Breakdown of academic impact, for papers by Olga Graciela Cantú‐Rodríguez Breakdown of academic impact, for papers by Paola De Lorenzo Breakdown of academic impact, for papers by Payal Desai Breakdown of academic impact, for papers by Maurizio Miano Breakdown of academic impact, for papers by Nicole A. Mortier
Rankless by CCL
2026